Research programme: leucocyte elastase inhibitors - Dainippon Sumitomo Pharma

Drug Profile

Research programme: leucocyte elastase inhibitors - Dainippon Sumitomo Pharma

Alternative Names: BL-3879; BL-5160; HNE inhibitors research programme - Dainippon Pharmaceutical; Human neutrophil elastase inhibitors research programme - Dainippon Pharmaceutical; Leucocyte elastase inhibitors research programme - Dainippon Pharmaceutical; Research programme: HNE inhibitors - Dainippon Pharmaceutical; Research programme: human neutrophil elastase inhibitors - Dainippon Pharmaceutical

Latest Information Update: 08 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dainippon Sumitomo Pharma
  • Class
  • Mechanism of Action Leucocyte elastase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Chronic obstructive pulmonary disease

Most Recent Events

  • 08 Feb 2008 Discontinued - Preclinical for Chronic obstructive pulmonary disease in Japan (PO)
  • 01 Oct 2005 Sumitomo Pharmaceuticals has merged with Dainippon Pharmaceutical to form Dainippon Sumitomo Pharma
  • 23 Sep 2005 Preclinical trials in Chronic obstructive pulmonary disease in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top